Peter Bains
Chief Executive Officer at BIOCON LIMITED
Net worth: 231 114 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Chris Cargill | M | 40 |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | 7 years |
| Mayank Verma | M | - | 12 years | |
| Siddharth Mittal | M | 46 | 11 years | |
| Mark Crossley | M | - | 12 years | |
| Ryan Preblick | M | - | 12 years | |
| Nagy Habib | M | 72 |
Mina (Holdings) Ltd.
 Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments.
MiNA Therapeutics Ltd.
 MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | 16 years |
| Vijay Kumar Kuchroo | M | 68 | 9 years | |
| Michael Wyzga | M | 69 | 5 years | |
| Paul Blackburn | M | 70 | 10 years | |
| Kieran Johnson | M | 55 |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments.
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | - |
| Denise Scots-Knight | M | 64 | 9 years | |
| Kiran Mazumdar-Shaw | F | 71 | 46 years | |
| Robert Sebastian Habib | M | 39 |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments.
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | - |
| Graham Hetherington | M | 65 | 5 years | |
| Akhilesh Nand | M | - | 6 years | |
| Joanna Le Couilliard | F | 60 | 3 years | |
| Tomohiro Toyama | M | 74 | 13 years | |
| Robert Lechler | M | - |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | 2 years |
| Juliet Thompson | F | 57 | 3 years | |
| Susan Clement Davies | F | 62 |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | 2 years |
| Nicholas Haggar | M | 59 | 1 years | |
| Rekha Mehrotra Menon | M | - | 1 years | |
| Kathryn Hudson | F | 50 | 9 years | |
| Saurabh Paliwal | M | - | - | |
| David Roblin | M | 57 | 6 years | |
| Keith Humphreys | M | - | 1 years | |
| Kazuhiko Yoshizumi | M | 70 | 9 years | |
| Deepa Pakianathan | M | 59 | 5 years | |
| Kuniaki Kaga | M | 72 | 6 years | |
| Bobby Kanubhai Parikh | M | 60 | 6 years | |
| Naina Lal Kidwai | F | 67 | 2 years | |
| Christopher Barry Wood | M | 78 |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments.
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | - |
| Jonathan Hunt | M | 55 | 9 years | |
| William H. Stimson | M | - |
ILC Therapeutics Ltd.
 ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Anders Olof Adolf Ekblom | M | 70 | 9 years | |
| Barbara Ryan | F | 64 | 2 years | |
| Damodaran Meleveetil | M | 77 | 8 years | |
| Mark Stejbach | M | 61 | 3 years | |
| Shreehas Tambe | M | - | 27 years | |
| Richard Francis | M | - | 5 years | |
| Cynthia Cetani | F | - | 6 years | |
| Hillel West | M | - | - | |
| Robert Kopple | M | 80 |
Mina (Holdings) Ltd.
Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is an investment holding British company founded in 2014. The private company is based in London, UK. The company's main function is to hold investments. | - |
| Ravi Rasendra Mazumdar | M | 69 | 24 years | |
| Manoj Kumar Pananchukunnath | M | - | - | |
| Hazel Allen | F | 57 |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Suba Krishnan | M | 59 | 4 years | |
| Christine Fox | F | 43 | 3 years | |
| Calvin Printer | M | - | - | |
| Vishal Kalia | M | - | - | |
| Tim Owens | M | - | - | |
| Christopher Cargill | M | - |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | - |
| Declan Doogan | M | 72 |
Apterna Ltd.
| - |
| Paul Vazhayil Thomas | M | - | - | |
| Amitava Saha | M | 54 | 11 years | |
| Jeremy Bender | M | 52 | 4 years | |
| Wills Hughes-Wilson | F | 53 | 6 years | |
| Seema Shah Ahuja | F | 57 | - | |
| Jeffrey Burris | M | 52 | 3 years | |
| Alistair Strachan | M | - |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Robert Kopple | M | 81 |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | - |
| John Lewicki | M | 72 | 4 years | |
| Pierre Jacquet | M | 57 | 3 years | |
| Gur Roshwalb | M | 55 |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | 4 years |
| Jerome Lande | M | 48 | 3 years | |
| Christian Heidbreder | M | - | 10 years | |
| Richard Simkin | M | - | - | |
| Jon Fogle | M | - | 10 years | |
| Alan Keith Walker | M | 80 |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | 4 years |
| Ian Hunter | M | - |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Kevin Grainger | M | - |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | - |
| Jason Thompson | M | - | - | |
| Eric Mazumdar | M | 31 | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter John Fellner | M | 80 | 7 years | |
| Hidetoshi Torami | M | 57 | 8 years | |
| Daniel Tassé | M | 64 | 7 years | |
| Bala S. Manian | M | 77 | 5 years | |
| Suresh Narasappa Talwar | M | 86 | 4 years | |
| Purushottam Singnurkar | M | - | - | |
| Lorna Parker | F | - | 9 years | |
| A. McLellan | M | 76 | 10 years | |
| Richard Jones | M | 58 | 3 years | |
| Sophia Chiniwar | F | - |
Fermenta Biotech Ltd. /Old/
 Fermenta Biotech Ltd. /Old/ BiotechnologyHealth Technology Fermenta Biotech Ltd. manufactures biological products. It supplies Vitamin D3, cholecalciferol also know as Vitamin D3 for further applications in global pharmaceutical, food, veterinary and feed industries (premix), cholecalciferol solutions for use in human food supplements, Vitamin D3 resin in oil and Vitamin D3 500 feed grade for use in animal feed supplements and activated dimethicone powder (Silicon Powder) for antiflatulent use. The company was founded in 1986 and is headquartered in Thane, India. | - |
| Guan Hong Tan | M | - |
The University of Sheffield
| 8 years |
| Krishna Vasantkumar Datla | M | 42 |
Fermenta Biotech Ltd. /Old/
Fermenta Biotech Ltd. /Old/ BiotechnologyHealth Technology Fermenta Biotech Ltd. manufactures biological products. It supplies Vitamin D3, cholecalciferol also know as Vitamin D3 for further applications in global pharmaceutical, food, veterinary and feed industries (premix), cholecalciferol solutions for use in human food supplements, Vitamin D3 resin in oil and Vitamin D3 500 feed grade for use in animal feed supplements and activated dimethicone powder (Silicon Powder) for antiflatulent use. The company was founded in 1986 and is headquartered in Thane, India. | - |
| Shaun Thaxter | M | - | - | |
| Paul Blackburn | M | - | 5 years | |
| Kunasingam V. Sittampalam | M | 72 |
The University of Sheffield
| 6 years |
| Charles Cooney | M | 80 | 14 years | |
| Takuya Fujii | M | 78 | 12 years | |
| Lizabeth Zlatkus | F | 65 | 3 years | |
| Kunal Ashok Kashyap | M | 59 | 6 years | |
| Daniel Phelan | M | 74 | 9 years | |
| Tatjana Anni Hilde May | F | 58 | 3 years | |
| Malcolm Weir | M | 65 | - | |
| John Russell Fotheringham Walls | M | 80 | 8 years | |
| Richard Bungay | M | 55 | - | |
| Julia Gregory | F | 71 | 3 years | |
| Daniel Bradbury | M | 62 | 3 years | |
| Indranil Sen | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 37 | 37.00% |
| India | 30 | 30.00% |
| United States | 26 | 26.00% |
| Japan | 9 | 9.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Bains
- Personal Network
